Lymphoma is a clinically and biologically heterogeneous disease. Next-generation sequencing (NGS) has expanded our understanding of this heterogeneity at the genetic level, refining disease classification, defining new entities, and providing additional information that can be used in diagnosis and management. This review highlights some of the NGS findings in lymphoma and how they can be used as genetic biomarkers to aid diagnosis and prognosis and guide therapy.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.path.2023.01.010 | DOI Listing |
Publication Analysis
Top Keywords
next-generation sequencing
8
diagnostic prognostic
4
prognostic predictive
4
predictive role
4
role next-generation
4
sequencing mature
4
mature lymphoid
4
lymphoid neoplasms
4
neoplasms lymphoma
4
lymphoma clinically
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!